| Phenotype | The endpoint of interest was ischemic stroke. In each trial, ischemic stroke was formally adjudicated by an independent clinical endpoint committee blinded to treatment assignment. |
| Sample Ancestry | European |
| Total number | 51,288 individuals |
| Detailed numbers |
960 cases (1.87%)
50,328 controls
71.7% Male samples
|
| Participant Follow-up Time | Median : 2.5 years |
| Age of Study Participants |
|
| Number of Cohort(s) | 5 |
Cohort Short Name
|
Cohort Full Name
|
Previous/other/additional names (e.g. sub-cohorts)
|
|---|---|---|
| ENGAGE_AF-TIMI_48 | ENGAGE AF-TIMI 48 | ENGAGE AF-TIMI 48 |
| FOURIER | FOURIER | — |
| PEGASUS-TIMI_54 | PEGASUS-TIMI 54 | PEGASUS-TIMI 54 |
| SAVOR-TIMI_53 | SAVOR-TIMI 53 | SAVOR-TIMI 53 |
| SOLID-TIMI_52 | SOLID-TIMI 52 | SOLID-TIMI 52 |